GAUDIO, Eugenio
 Distribuzione geografica
Continente #
NA - Nord America 262
EU - Europa 143
AS - Asia 133
Continente sconosciuto - Info sul continente non disponibili 3
AF - Africa 1
Totale 542
Nazione #
US - Stati Uniti d'America 254
SG - Singapore 95
IT - Italia 82
CN - Cina 20
GB - Regno Unito 20
DE - Germania 14
SE - Svezia 13
CA - Canada 8
HK - Hong Kong 8
IN - India 8
CZ - Repubblica Ceca 5
EU - Europa 3
NL - Olanda 3
FI - Finlandia 2
FR - Francia 2
EE - Estonia 1
IR - Iran 1
MU - Mauritius 1
MY - Malesia 1
UA - Ucraina 1
Totale 542
Città #
Chandler 48
Singapore 36
Santa Clara 23
Ashburn 21
London 20
Catanzaro 14
Vallefiorita 14
Chicago 13
Milan 12
Princeton 12
Lawrence 11
Wilmington 8
Hong Kong 6
Ottawa 6
Luni 5
Olomouc 5
Des Moines 4
Hanover 4
Pune 4
Castrolibero 3
Munich 3
Rome 3
Assago 2
Bathinda 2
Boardman 2
Guangzhou 2
Helsinki 2
Leawood 2
Los Angeles 2
Padova 2
Paris 2
Peterborough 2
Phoenix 2
Pontedera 2
Taranto 2
Troina 2
Wan Chai 2
Washington 2
Amsterdam 1
Ann Arbor 1
Aversa 1
Cagliari 1
Chongqing 1
Council Bluffs 1
Cupertino 1
Kuala Lumpur 1
Mumbai 1
Nagold 1
Norwalk 1
Parsberg 1
Pingdingshan 1
Port Louis 1
Rende 1
San Mateo 1
Seattle 1
Secaucus 1
Settingiano 1
Shanghai 1
Shaoxing 1
Shenyang 1
Shenzhen 1
Stezzano 1
The Dalles 1
Torre Del Lago 1
Treviso 1
Vancouver 1
Totale 335
Nome #
Pyrrolo[2′,3′:3,4]cyclohepta[1,2- d][1,2]oxazoles, a New Class of Antimitotic Agents Active against Multiple Malignant Cell Types 48
The receptor protein tyrosine phosphatase PTPRJ negatively modulates the CD98hc oncoprotein in lung cancer cells. 44
Isolation and Functional Characterization of Peptide Agonists of PTPRJ, a Tyrosine Phosphatase Receptor Endowed with Tumor Suppressor Activity. 44
Abstract B122: The CD98hc oncoprotein as a target of new anticancer therapy 36
A Fhit-mimetic peptide suppresses annexin A4-mediated chemoresistance to paclitaxel in lung cancer cells 36
Fhit-Fdxr interaction in the mitochondria: modulation of reactive oxygen species generation and apoptosis in cancer cells 33
TCL1A interacts with TP63 and enhances the survival of Raji Burkitt lymphoma cell line. 32
Discovery of PTPRJ Agonist Peptides That Effectively Inhibit in Vitro Cancer Cell Proliferation and Tube Formation. 32
BRCA1 5083del19 mutant allele selectively up-regulates periostin expression in vitro and in vivo 31
A novel splice variant of the protein tyrosine phosphatase PTPRJ that encodes for a soluble protein involved in angiogenesis 31
Genetic ablation of Ptprj, a mouse cancer susceptibility gene, results in normal growth and development and does not predispose to spontaneous tumorigenesis 25
Multi-targeting bioactive compounds extracted from essential oils as kinase inhibitors 24
Protein tyrosine phosphatase PTPRJ is negatively regulated by microRNA-328 23
Development of [1,2]oxazoloisoindoles tubulin polymerization inhibitors: Further chemical modifications and potential therapeutic effects against lymphomas 23
Fhit delocalizes Annexin A4 from plasma membrane to cytosol and sensitizes lung cancer cells to paclitaxel 23
Discovery of PTPRJ agonist peptides that effectively inhibit in vitro cancer cell proliferation and tube formation 22
PTPRJ agonist peptides effectively inhibit in vitro cancer cell proliferation and tube formation 22
The Tumour Suppressor Fhit Protein Activates C-Raf Ubiquitination and Degradation in Human Melanoma Cells by Interacting with Hsp90 15
null 14
Transcriptome and computational analysis assess the anti-tubulin activity of [1,2]oxazole derivatives in lymphoma 12
Identification of pyrrolo[3′,4’:3,4]cyclohepta[1,2-d][1,2]oxazoles as promising new candidates for the treatment of lymphomas 9
Evaluation of [1,2]oxazolo[5,4-e]isoindoles in lymphoma cells 6
A first-in-class Wiskott-Aldrich syndrome protein (WASp) activator with anti-tumor activity in hematological cancers 4
A first-in-class Wiskott-Aldrich syndrome protein activator with antitumor activity in hematologic cancers 4
Totale 593
Categoria #
all - tutte 7.468
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.468


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20206 0 0 0 0 0 0 0 0 0 0 0 6
2020/202147 2 0 2 0 0 13 23 0 0 6 1 0
2021/202243 0 0 0 12 2 2 0 10 5 7 5 0
2022/2023147 23 8 12 14 14 13 4 13 22 10 10 4
2023/2024127 20 17 3 13 7 44 3 2 1 1 6 10
2024/2025217 32 8 13 7 32 31 26 8 55 5 0 0
Totale 593